Back to Trades
GORDON CARL L
DirectorCIK 0001282930
Profile
- Filings
- 7
- Buy transactions
- 2
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Across 7 filings between 2025–2026, GORDON CARL L, Director, has disclosed $29.4M in transactions — spread across 3 companies. Their disclosed trades are heavily weighted toward buying — $25.0M in buys and $0 in sells. The largest single open-market purchase on record is $15.0M in Scribe Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Aug 12 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Director | Buy | $10.0M |
| Aug 10 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Insider | Award | $382.5K |
| Aug 6 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Jul 29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Director | Buy | $15.0M |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Dec 18 | KROS Keros Therapeutics, Inc. | GORDON CARL L | Director | Disposed | $3.8M |
7 filings